Observational Study of Switching from Natalizumab to Immunomodulatory Drugs

Publisher: Karger

E-ISSN: 1421-9913|77|3-4|130-136

ISSN: 0014-3022

Source: European Neurology, Vol.77, Iss.3-4, 2017-01, pp. : 130-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract